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Abstract
We isolated a full-length cDNA encoding human caveolin 3, which is 72% and 59% homologous to human caveolin 1
and caveolin 2, respectively. Human caveolin 3 protein contains the ‘caveolin signature sequence’ and the 33 amino acids
spanning intramembrane domain common to all caveolins. Northern blot analysis indicates that the caveolin 3 transcript is
1.6 kb in size and exclusively detectable in muscle tissue. q 1998 Elsevier Science B.V.
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1. Introduction
The lateral assembly of sphingolipids and choles-
terol creates microdomains, so-called rafts, which are
floating in a glycerophospholipid rich environment.
The rafts recruit a specific set of proteins and exclude
others and thereby regulate numerous cellular func-
tions, including membrane traffic, cell morphogenesis
w xand signal transduction 1,2 . Caveolae, flask-shaped
w xplasma membrane invaginations 3 , are special rafts,
characterized by the presence of caveolins, a protein
family of about 23 kDa, that form a hairpin structure
in the membrane, with their amino and carboxy
w xtermini located on the cytosolic side 4 . Caveolae are
a particularly abundant and characteristic feature of
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endothelial cells, adipocytes and fibroblasts but are
w xthought to exist in most cell types 5 . Recently,
caveolae were also demonstrated in the plasma mem-
w xbrane of activated macrophages 6 .
Caveolin is highly expressed in those tissues with
w xabundant caveolae 7 . Furthermore, overexpression
of caveolin-1 in lymphocytes lacking caveolae in-
duces the formation of caveolae at the cell surface
w x8 . This close relationship between caveolin expres-
sion and the appearance of caveolae points out the
role of caveolins in the morphogenesis of these
cholesterol-sphingolipid rafts. In addition, caveolin 1
homo-oligomers of about 350 kDa may form the
scaffold on which caveolin interacting signaling
molecules are organized the caveolae signaling hy-
. w xpothesis 9 .
A caveolin 1 related protein, caveolin 2, has been
w xidentified as a product of a separate gene 10 . Thus a
new caveolin gene family could be defined. Caveolin
3, the third member of this gene family, has been
w xcloned from rat and mouse libraries 11,12 and is
thought to participate in the T-tubule biogenesis in
w xskeletal muscle cells 13 . Furthermore caveolin 3
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co-localizes with dystrophin to the sarcolemma of
muscle fibers and coimmunoprecipitates with dys-
w xtrophin 14 . In this regard the search for mutations in
the caveolin 3 gene of patients with unknown causes
of muscular dystrophy is of great promise. The com-
plete cDNA for human caveolin 3 and its tissue
specific expression in skeletal and heart muscle cells,
is the first step towards the identification of this gene
in Duchenne muscular dystrophy.
2. Cloning of human caveolin 3 cDNA
Therefore, we tried to clone the human homologue
because only the rat and mouse caveolin 3 sequences
w xare published 11,12 . Prim ers cav 554
 X X.5 TCGCAGCACCACCTTAATGTTGCT3 and cav
 X219 5 CCAAGAACATCAATGAGGACATT-
X.GTG3 were designed from a region, which is highly
homologous between the rat and mouse caveolin 3,
and used them to amplify a single 358 bp band by
PCR from human skeletal muscle cDNA. The skele-
tal muscle cDNA was used as caveolin 3 shows a
w xmuscle specific expression 14 . The obtained 358 bp
product was cloned into pUC 18, sequenced and the
sequence homology between the human sequence and
rat or mouse caveolin 3 was very high. In order to
identify the 5X-end of human caveolin 3 cDNA
marathon ready TM cDNA prepared from human
 .q skeletal muscle poly A RNA Clontech, Palo Alto,
.CA was amplified according to the instructions of
the manufacturer. A primary PCR reaction was con-
ducted with the provided anchor primer and the
 Xcaveolin specific primer hcav 135 5 CACAG-
X.GCTCTGCGATCACGTCTTCA3 complementary
to nucleotide positions 135 to 160. One single band
was obtained, cloned into pUC 18 and sequenced. To
identify the 3X-end of the human caveolin 3 cDNA a
primary PCR reaction was performed with the anchor
primer and the caveolin gene specific primer hcav
 X X.259 5 CCACTGGGCCTGCTCTGGGGCTTCC3 .
An aliquot of the initial PCR reaction served as
 .template in a secondary PCR reaction nested PCR
using the nested anchor primer and two different
nested gene specific primers: hcav 371
 X X .5 TCTACTCACTCTGCATCCGCACCTTCTG3
 Xand hcav 403 5 CCACTCTTCGCGGCCCTGGGC-
X.CAGGTC3 . The primer name indicates the location
in the nucleotide sequence in the way that the posi-
tion of the first primer nucleotide is mentioned. All
PCR products were analyzed on an 1.5% agarose gel,
blotted onto nylon membranes and hybridized with
primer cav 554. The verified DNA fragments were
cloned into pUC 18 and sequenced.
The complete sequence of human caveolin 3 com-
 .prises 1291 base pairs Fig. 1 . An open reading
frame encoding a protein with 151 amino acids and a
predicted mass of 17.2 kDa is observed. Rat and
mouse caveolin 3 show the same number of amino
w xacids 11,12 . The cDNA for human caveolin 3 con-
tains a start codon at position 12 and a polyadenyla-
tion signal AAATAAA at nucleotide 1250. The
 .qpoly A tail starts at position 1260.
Fig. 1. Nucleotide and amino acid sequence of human caveolin 3.
The caveolin signature sequence is indicated by a boldface
overline, the transmembrane domain is overlined. Differing amino
acids between human and mouse caveolin 3 are boxed. The three
 .conserved cysteine residues sites of palmitoylation in caveolin 1
are shown in bold and underlined. The polyadenylation signal is
marked in bold.
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3. Sequence comparison of human caveolin 3 cDNA
Data base searches using the FASTA programme
with the human caveolin 3 nucleotide sequence re-
vealed that the most homologous cDNA belongs to
mouse caveolin 3, because 89% of the nucleotides are
identical between mouse and human caveolin 3 Fig.
. X2 . The 3 -untranslated region of both caveolins could
not be compared because of the lack of sequence
information on mouse caveolin 3 where only the
coding region sequence is published. Additionally the
expressed sequence tag hs1224 showed a sequence
homology of 99% concerning the 3X-untranslated re-
gion of the caveolin cDNA. Human caveolin 3 cDNA
Fig. 2. Data base search with the human caveolin 3 cDNA. The
FASTA programme revealed as the most homologous sequence
the mouse caveolin 3 cDNA. 89% of the coding region are
identical in human and mouse caveolin 3 cDNA.
 .is most closely related to caveolin 1 72% identity
 .and is most distant from caveolin 2 59% identity .
Human caveolin 3 protein sequence differs only in 8
amino acids from the mouse or rat caveolin 3 result-
ing in an identity of 95%.
w xSimilar to caveolin 1 15 , most of the differences
 .between human and mouse rat caveolin-3 are lo-
cated in the amino- and carboxylterminal ends of the
 .protein with a long central stretch 15–142 contain-
 .ing only two different amino acids Fig. 1 . In addi-
tion, caveolin 1 isoforms a and b differ only in the
length of the N-terminus through alternate initiation
w xduring translation 16 . The long conserved stretch
contains a 33 amino acid hydrophobic domain re-
.sidues 74–107 , that is predicted to form a hairpin
loop in the membrane allowing both the N- and
w xC-termini to remain entirely cytosolic 4 . This do-
main is probably important for caveolin targeting
because the length and the sequence of this region is
w xconserved 12 . Another domain, the so called cave-
olin signature sequence consisting of eight amino
 .acids FEDVIAEP starts with residue 41. This unique
region is conserved between all caveolins and may
therefore present a characteristic feature of the cave-
w xolin gene family 11 . Furthermore the G-protein
interacting motif contains only one conservative sub-
 .stitution position 59 K“R . This caveolin 3 de-
rived peptide was shown to stimulate the GTPase
w xactivity of purified heterotrimeric G-proteins 11 .
Additionally the three cysteine residues which are
palmitoylated in human caveolin 1 are conserved in
caveolin 3, suggesting that human caveolin 3 under-
w xgoes palmitoylation as well 17 .
4. Expression pattern of human caveolin 3 mRNA
The expression of human caveolin 3 mRNA in
different tissues, fibroblasts and monocytes was ex-
amined by Northern blotting. The blots were per-
formed with a 577 bp probe spanning nearly the
whole coding region. As the caveolin 1 coding se-
quence is highly homologous to caveolin 3 the probe
recognizes both caveolin 1 and caveolin 3 resulting in
w xtwo bands one at 2.1 kb for caveolin 1 7 and the
other at 1.6 kb for caveolin 3. The cDNA sequence is
about 300 bp shorter than the mRNA length de-
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tectable in Northern blots. This difference is either
 .qderived from a very long poly A tail or from a
missing sequence of the 5X untranslated region. Fur-
ther analysis of the transcription start sites and pro-
moter dependent regulation of human caveolin 3
mRNA expression will answer this question. How-
ever, since the 5X-untranslated region is usually rather
 .qshort, a long poly A tail seems to be the more
likely explanation. Using a multiple tissue blot
 .Clontech caveolin 3 mRNA was detected only in
 .skeletal muscle and heart Fig. 3, panel A . In the
other tissues no band was observed even after expo-
sure times of one week. A cell-specific Northern blot
performed with mRNA from primary fibroblast cul-
ture showed that despite the great abundance of
caveolae in these cell type no caveolin 3 mRNA is
expressed. Moreover HDL -treatment of fibroblasts3
leads to a significant upregulation of caveolin 1
 .mRNA Fig. 3, panel B while the caveolin 3 mRNA
levels could not be induced through HDL -treatment.3
Since the caveolin 3 mRNA in contrast to caveolin 1
is neither detectable in fibroblasts nor inducible by
HDL -treatment, we presume that caveolin 3 may not3
contribute to the formation of caveolae in fibroblasts.
The increased caveolin 1 signal indicates additionally
to the right size of 2.1 kb that the probe recognizes in
fact caveolin 1. Why heart and skeletal muscle cells
coexpress caveolins 1 and 3 in contrast to fibroblasts
remains unknown and it has to be further investigated
why in muscle a third caveolin is necessary and
whether distinct subsets of caveolae exist in sar-
colemma that differ in their caveolin content from the
 .  .Fig. 3. Tissue specific expression of human caveolin 3 analyzed by means of Northern blot. A The multiple tissue blot Clontech
 . w32 xcontaining 2 mg poly A RNA of the indicated human tissues was hybridized with a P -labeled human caveolin 3 cDNA, which
crossreacts with caveolin 1. The membranes were prehybridized for 1 h in 50 mM PIPES, 100 mM NaCl, 50 mM sodium phosphate, 1
w32 xmM EDTA, 5% SDS at 608C and then hybridized overnight with a random hexamer P -labeled probe generated from a 577 bp
cDNA-fragment of caveolin 3 reaching from position 1 to 576. The blots were washed in SSC, 5% SDS for 20 min at room temperature
 .followed by a stringent wash at 608C for 20 min. Filters were exposed to a Kodak X-ray film for 24 h with an intensifying screen. B
 .THP-1 cells were cultured in the presence of 160 nM phorbol 12-myristate-13-acetate PMA . Upon addition of PMA, THP-1 cells,
which are propagated in suspension, stop dividing, become adherent, and differentiate to macrophage-like state. Human monocytes were
isolated from healthy volunteers by leukapheresis and subsequent counterflow centrifugation. Fibroblasts were incubated with 100 mg
w xHDL rml medium for 12 h. HDL was freshly prepared as previously described 19 . Total RNA was isolated using the isothio-3 3
w  .xcyanatercesium chloride method. 10 mg of total RNA were loaded on each lane and hybridized with a caveolin 3 probe see A . Equal
RNA loading was verified through EtBr-staining of the RNA. Ribosomal bands are indicated
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cell membrane caveola. In skeletal muscle tissue the
caveolin 1 band derives from endothelial and not
w xfrom muscle cells 11 . The expression of human
caveolin 3 mRNA in freshly isolated monocytes and
cultured monocytes was of interest because caveolae
w xare detectable in macrophages 6 and an upregulation
of caveolin 1 mRNA during monocytic differentia-
 .tion was observed data not shown . No caveolin 3
mRNA was detectable in differentiated monocytes
and in cells from the monocytic cell line THP-1, that
was induced to differentiate toward a macrophage-like
 . w xstate by culture with phorbol ester PMA 18 under-
lining the restricted expression pattern of human
caveolin 3 mRNA.The muscle specific expression
pattern of human caveolin 3 is unique among the
caveolin gene family, because caveolin 1 and cave-
w xolin 2 are expressed in nearly all cell types 5 . The
exact role of a specific caveolin in muscle cells
remains unknown. However, it was shown by immu-
noelectron microscopy that dystrophin, a cytoskeletal
anchoring protein localized in the sarcolemma of
differentiated C2C12 skeletal myoblasts, associates
with caveolin 3. Thus a role of caveolin 3 in the
pathogenesis of muscular dystrophy is discussed. The
sequence and tissue distribution of human caveolin 3
mRNA will facilitate investigations concerning the
formation of muscular dystrophy.
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